A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) Combinations in Adult Participants With Advanced Solid Tumors
This study is testing new combinations of cancer medications, including an experimental drug called BMS-986507, in adults with advanced solid tumors like lung or breast cancer. Researchers want to find the safest and most effective doses to help treat these types of cancer.
You might be eligible if you are an adult with advanced lung or breast cancer that has measurable tumors on scans, and you are able to carry out light daily activities. There are specific rules about your previous treatments and overall health that your doctor will check.
Participants will receive study medications, which are either experimental drugs or known cancer therapies given in combination. The medical team will closely monitor your safety, track how the drugs move through your body, and see how well the treatment works.
The study is currently recruiting participants at locations in the United States, including cities in Alabama, Florida, and Iowa. Your care team will let you know which specific clinic is best for you.
- 1Tests new drug combinations for advanced lung and breast cancer
- 2Currently recruiting patients at select locations in the U.S.
- 3Focuses on finding the right dose for safety and effectiveness
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.